Ottavio Arancio

Ottavio Arancio

Taub Institute for Research on Alzheimer's Disease and Aging Brain, Columbia University

Affiliated withColumbia UniversityColumbia College

Research Area

Biography

Ottavio Arancio has not added Biography.
If you are Ottavio Arancio and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Preparation of Oligomeric &beta;-amyloid<sub>1-42</sub> and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Publication title

Cited by 74

2010

Other Publications

Article
Year
Calpain inhibitors: a treatment for Alzheimer's disease.

Journal of molecular neuroscience : MN| PubMed ID: 12212771

2002
Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 12244210

2002
2003
2003
2003
Calpain inhibitors, a treatment for Alzheimer's disease: position paper.

Journal of molecular neuroscience : MN| PubMed ID: 14501020

2003
2004
2004
2004
2004
2004
2004
2004
2004
ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 15665036

2005
2005
Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 16033898

2005
Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 16399702

2006
2006
2006
2006
2006
2006
2006
Neurotrophins, synaptic plasticity and dementia.

Current opinion in neurobiology| PubMed ID: 17419049

2007
2007
2009
2007
2008
2007
2007
2008
2008
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 18480253

2008
2008
2008
Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 18591654

2008
2008
2008
Role of phosphodiesterase 5 in synaptic plasticity and memory.

Neuropsychiatric disease and treatment| PubMed ID: 18728748

2008
2008
2008
2008
Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 19118188

2008
2009
Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.

Mini reviews in medicinal chemistry| PubMed ID: 19356123

2009
Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology| PubMed ID: 19516252

2009
Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 19553447

2009
2009
Reversal of long-term dendritic spine alterations in Alzheimer disease models.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19805389

2009
MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE.

Expert review of neurotherapeutics| PubMed ID: 19903023

2009
The ARMS/Kidins220 scaffold protein modulates synaptic transmission.

Molecular and cellular neurosciences| PubMed ID: 20547223

2010
PIP2: a new key player in Alzheimer's disease.

Cellscience| PubMed ID: 20577650

2008
2010
2010
Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 21048150

2010
Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21098268

2010
Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 21147981

2010
2011
2011
2011
2011
2011